0001140361-17-035899.txt : 20170919 0001140361-17-035899.hdr.sgml : 20170919 20170919151752 ACCESSION NUMBER: 0001140361-17-035899 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170915 FILED AS OF DATE: 20170919 DATE AS OF CHANGE: 20170919 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: FUCHS HENRY J CENTRAL INDEX KEY: 0001197355 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-26727 FILM NUMBER: 171091913 MAIL ADDRESS: STREET 1: C/O BIOMARIN PHARMACEUTICAL INC. STREET 2: 105 DIGITAL DRIVE CITY: NOVATO STATE: CA ZIP: 94949 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOMARIN PHARMACEUTICAL INC CENTRAL INDEX KEY: 0001048477 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 680397820 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 105 DIGITAL DRIVE CITY: NOVATO STATE: CA ZIP: 94949 BUSINESS PHONE: 4155066700 MAIL ADDRESS: STREET 1: 105 DIGITAL DRIVE CITY: NOVATO STATE: CA ZIP: 94949 4 1 doc1.xml FORM 4 X0306 4 2017-09-15 0 0001048477 BIOMARIN PHARMACEUTICAL INC BMRN 0001197355 FUCHS HENRY J C/O BIOMARIN PHARMACEUTICAL INC. 770 LINDARO ST. SAN RAFAEL CA 94901 0 1 0 0 President, Worldwide R&D Common Stock 2017-09-15 2017-09-15 4 M 0 5000 26.49 A 141422 D Common Stock 2017-09-15 2017-09-15 4 M 0 10000 37.46 A 151422 D Common Stock 2017-09-15 2017-09-15 4 S 0 15000 90.50 D 136422 D Stock Option (right to buy) Common Stock 26.49 2017-09-15 2017-09-15 4 M 0 5000 0 D 2011-11-12 2021-05-11 Common Stock 5000 10225 D Stock Option (right to buy) Common Stock 37.46 2017-09-15 2017-09-15 4 M 0 10000 0 D 2012-11-08 2022-05-07 Common Stock 10000 37934 D Trade made pursuant to a 10b5-1 plan executed on May 9, 2017. The price in column 4 is the weighted average price. The price actually received ranged from $89.26 to $91.89. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price. Reflects the number of options outstanding after the transactions from this specific stock option grant. /s/ Laura Randall Woodhead, Attorney-in-Fact 2017-09-19